22nd Century Group ( NASDAQ:XXII – Get Rating ) posted its earnings results on Thursday. The biotechnology company reported ($0.12) EPS for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.06), reports. The business had revenue of $19.21 million for the quarter, compared to analysts' expectations of $19.26 million. 22nd Century Group had a negative net margin of 96.28% and a negative return on equity of 64.42%. 22nd Century Group Stock Up 0.7 % Shares of 22nd Century Group stock opened at $0.

https://www.dailypolitical.com/2023/03/12/22nd-century-group-nasdaqxxii-issues-earnings-results.html

#dailypolitical